Publications

Home
Sites
News
Publications
Contact

Publications

BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years
Clinical Infectious Diseases
August 4, 2022

Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C
Pediatrics
June 29, 2022

Treatment of Multisystem Inflammatory Syndrome in Children: Understanding Differences in Results of Comparative Effectiveness Studies
ACR Open
June 27, 2022

Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants
New England Journal of Medicine
June 22, 2022

Preliminary data reported in MMWR:
Effectiveness of Maternal Vaccination with mRNA COVID-19 Vaccine During Pregnancy Against COVID-19–Associated Hospitalization in Infants Aged <6 Months — 17 States, July 2021–January 2022
Morbidity and Mortality Weekly Report
February 15, 2022

Life-Threatening Complications of Influenza versus COVID-19 in U.S. Children
Clinical Infectious Diseases
June 19, 2022

Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
Nature Communications
May 27, 2022

BNT162b2 Protection against the Omicron Variant in Children and Adolescents
New England Journal of Medicine
March 30, 2022

Measurement of SARS-CoV-2 antigens in plasma of pediatric patients with acute COVID-19 or MIS-C using an ultrasensitive and quantitative immunoassay
Clinical Infectious Diseases
February 25, 2022

Systemic and Lower Respiratory Tract Immunity to SARS-CoV-2 Omicron and Variants in Pediatric Severe COVID-19 and MIS-C
Vaccines
February 10, 2022

Immunology of SARS-CoV-2 infection in children
Nature Immunology
February 1, 2022

Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021
Morbidity and Mortality Weekly Report
January 14, 2022

Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents
New England Journal of Medicine 
January 12, 2022

Preliminary data reported in MMWR:
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021
Morbidity and Mortality Weekly Report
October 22, 2021

A Description of COVID-19-Directed Therapy in Children Admitted to US Intensive Care Units 2020
Journal of the Pediatric Infectious Disease Society
January 12, 2022

Frequency, Characteristics and Complications of COVID-19 in Hospitalized Infants
Pediatric Infectious Disease Journal
December 21, 2021

Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents
EClinicalMedicine
August 31, 2021

Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes
New England Journal of Medicine
June 16, 2021

Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
JAMA Neurology
March 5, 2021

Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
Journal of the American Medical Association
February 24, 2021

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
New England Journal of Medicine
June 29, 2020

Overcoming COVID-19 Copyright 2020 © All rights reserved.

Legal and Privacy Policy

Note: We are unable to provide clinical advice. If you have specific questions about your child’s health or clinical care, please contact their healthcare provider.

Privacy Policy

Contact

contact@overcomecovid.org

Website Designed by Cameron Young

Investigators Portal

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories

Essential

On

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

On

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.